Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in COPD Cachexia

NCT02442908
completednot_applicable

Improvement of Compliance for High Doses of EPA Amongst Patients With Colorectal Cancer

NCT03751384
completednot_applicable

Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in NSCLC Cachexia

NCT02515032

Clinical Trials (3)

Showing 3 of 3 trials
NCT02442908Not Applicable

Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in COPD Cachexia

Completed
NCT03751384Not Applicable

Improvement of Compliance for High Doses of EPA Amongst Patients With Colorectal Cancer

Completed
NCT02515032Not Applicable

Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in NSCLC Cachexia

Completed

All 3 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
3